CINA LVO

Avicenna.AI

The CINA LVO solution is designed to automatically detect and prioritize acute large vessel occlusions on CTA. It supports mobile and email notification, web browser preview and PACS export.
Product specifications Information source: Vendor
Last updated: July 20, 2020
General
Product name CINA LVO
Company Avicenna.AI
Subspeciality Neuro
Modality CT
Disease targeted stroke
Key-features large vessel occlusion detection, notification
Suggested use Before: adapting worklist order, flagging acute findings
Data characteristics
Population
Input CTA
Input format DICOM
Output worklist order, report
Output format DICOM SC, GSPS
Technology
Integration Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform
Deployment Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based
Trigger for analysis Automatically, right after the image acquisition
Processing time 10 - 60 seconds
Certification
CE Certified, Class I
FDA 510(k) cleared, Class II
Market presence
On market since 02-2020
Distribution channels Eureka Clinical AI
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model Pay-per-use, Subscription
Based on Number of installations, Number of analyses
Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers